In Zusammenarbeit mit der vascular risk foundation erarbeiten und validieren wir neue Konzepte in der Risikovorhersage zu Herz- und Kreislauferkrankungen.
Beispiele:
- Walter, P. and Tsakiris, D. and Romanens, M. and Kort, W. and Arnet, I. and Hersberger KE. Fundamental progress in investigating drug resistance with electronic multidrug compliance monitoring (e-MCM). J Patient Compliance 2017;1(2).
- Romanens M., Ackermann F., Sudano I., et al. LDL-cholesterol and the potential for coronary risk improvement. Kardiovaskuläre Medizin 2011;14(12):345–50.
- Romanens M., Sudano I., Szucs T., Adams A. Medical costs per QALY of statins based on Swiss Medical Board assumptions. Cardiovasc Med 2017;17:96–100.
- Romanens M., Mortensen MB., Sudano I., et al. Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators. Prev Med Reports 2017;6:182–6.
- Romanens M., Ackermann F., Sudano I., Szucs T., Spence JDD. Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction. Swiss Med Wkly 2014;144:w13967.